Internationally-recognized as a leading expert in the identification, development and progression of osteoarthritis, University of Arizona Arthritis Center Director C. Kent Kwoh, MD, is the first author on two abstracts to be presented at the 2023 Osteoarthritis Research Society International World Congress on Osteoarthritis. This year's conference will be held March 17-20 in Denver, Colorado. The annual OARSI Congress is the preeminent multidisciplinary global forum for those interested in cutting-edge osteoarthritis research from academia and industry around the world, including basic and clinical research scientists, rheumatologists, orthopedic surgeons, radiologists, physiatrists, physical therapists and other allied health professionals, methodologists, and policy makers (reference: oarsi.org - 2023).
Serving as first author on two poster presentations, Dr. Kwoh is also a collaborator on three additional abstracts. Titles and authors of the OARSI presentations are detailed below:
STRUCTURAL DAMAGE AND EFFECTS ON KNEE PAIN DURING DIFFERENT ACTIVITIES AS ASSESSED BY THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX (WOMAC)
CK Kwoh (1), F Roemer( 2), A Guermazi (3), EL Ashbeck (1)
(1) University of Arizona Arthritis Center, Tucson, AZ, USA; (2) University of Erlangen, Department of Radiology, Erlangen, Germany, (3) Boston University School of Medicine, Quantitative Imaging Center, Department of Radiology, Boston, MA, USA
QUANTITATIVE BONE MARROW LESION VOLUME AS A HARBINGER OF LONG-TERM KNEE CARTILAGE LOSS
CK Kwoh (1), EL Ashbeck (1), M Taljanovic (1), G Gilles (1), A Vohra (1), D Robles (1), EJ Bedrick (2), A Guermazi (3), J Duryea (4)
(1) University of Arizona Arthritis Center, Tucson, AZ, USA; (2) Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ, USA; (3) Department of Radiology, Boston University Medical Center, Boston, MA, (4) Brigham and Women's Hospital, Boston, MA, USA
RISK FACTORS FOR EXCLUSIONARY STRUCTURAL ELIGIBILITY FINDINGS IN DISEASE- MODIFYING OSTEOARTHRITIS DRUGS CLINICAL TRIALS
(1) Mohamed Jarraya, (2,3) Frank W. Roemer, (4) Erin L. Ashbeck, (5) John A. Lynch, (4) CK Kwoh, (2) Ali Guermazi
(1) Massachusetts General Hospital, Harvard Medical School, Boston, MA; (2) Boston University School of Medicine, Boston, MA; (3) Friedrich-Alexander-University Erlangen-Nurnberg (FAU), Erlangen, Germany; (4) University of Arizona, Tucson, AZ; (5) University of California, San Francisco, CA
HETEROGENEITY OF MRI-DETECTED CARTILAGE DAMAGE IN KELLGREN-LAWRENCE 2 & 3 KNEES AND IMPLICATIONS FOR CLINICAL TRIALS: THE OSTEOARTHRITIS INITIATIVE
(1) Mohamed Jarraya, (2,3) Frank W. Roemer, (4) Erin L. Ashbeck, (5) John A. Lynch, (4) CK Kwoh, (2) Ali Guermazi
(1) Massachusetts General Hospital, Harvard Medical School, Boston, MA; (2) Boston University School of Medicine, Boston, MA; (3) Friedrich-Alexander-University Erlangen-Nurnberg (FAU), Erlangen, Germany; (4) University of Arizona, Tucson, AZ; (5) University of California, San Francisco, CA
DOES PHYSICAL ACTIVITY CONFOUND RACE DIFFERENCE IN OSTEOARTHRITIS-RELATED FUNCTIONAL LIMITATION?
Ernest R. Vina (1), CK Kwoh (2), Carolina Villamil Grest (3), Jason T. Jakiela (4), Thomas Bye (4), and Daniel K. White (4)
(1) Section of Rheumatology, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA; (2) Division of Rheumatology and University of Arizona Arthritis Center, University of Arizona, Tucson, Arizona, USA; (3) School of Social Work, College of Public Health, Temple University, Philadelphia, Pennsylvania, USA; (4) Department of Physical Therapy, University of Delaware, Newark, DE